United States · Who invested in Pronutria Biosciences, Inc.?
Pronutria Biosciences, Inc.'s investors include Flagship Pioneering, LLC, Flagship Ventures and Rajiv Kaul.
20142015
$11MSeries A$39MSeries CUnited States · Series C startup
Who invested in Pronutria Biosciences, Inc.
2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$50Mraised across 2 rounds since 2013, from 2 sources
$11MSeries A$39MSeries C
- Latest round
- Series C, $39MMay 2015
- Step-upi
- 3.6×
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $11M Oct 2013
- Biggest round
- $39M Series C · May 2015
- Between rounds
- 19 months from the last two
The rounds
- May 2015Series C$39M2 new
- Flagship Ventures
- Rajiv Kaul
From a historical funding recordSEC filing: $39M sold, first sale Jan 2015
- Oct 2013
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Quick answers about Pronutria Biosciences, Inc.
How much has Pronutria Biosciences, Inc. raised?
Pronutria Biosciences, Inc. has raised $50M across 2 rounds since 2013.
When did Pronutria Biosciences, Inc. last raise?
Pronutria Biosciences, Inc.'s most recent round was a Series C of $39M in May 2015.
What was Pronutria Biosciences, Inc.'s biggest round?
Its most recent round, $39M in May 2015, is also its largest on record.
Who backed Pronutria Biosciences, Inc. first?
Pronutria Biosciences, Inc.'s first round on record, in Oct 2013, was backed by Flagship Pioneering, LLC.
What stage is Pronutria Biosciences, Inc. at?
Pronutria Biosciences, Inc.'s latest named round is a Series C, in May 2015.
Where is Pronutria Biosciences, Inc. based?
Pronutria Biosciences, Inc. is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.